Abstract:The goal of the present study is to identify the differential expression of circular RNA (circRNA), miRNA, and piwi-interacting RNA (piRNA) after lineage commitment towards osteoand chondrogenesis of human bone marrow mesenchymal stromal cells (hMSCs). The cells were maintained for 7 days in either osteogenic or chondrogenic medium. RNA sequencing was performed to assess the expression of miRNA and piRNA, while RNA hybridization arrays were used to identify which circRNA were differentially expressed. qPCR val… Show more
“…Recently several circRNAs, miRNAs and piRNA were differentially expressed after 7 days of chondrogenic and osteogenic induction ( Della Bella et al, 2020 ). This analysis identified 130 up and 97 downregulated circRNAs in chondrogenesis, of which 15 were also identified in osteogenesis.…”
Section: Gene Expression Profile In Chondrogenesis Of Mscmentioning
confidence: 99%
“…Investigating if the expression of these genes were influenced by dexamethasone, a component of both induction media ( Table 1 ), the cells were exposed only to the compound in monolayer or pellet culture. The results indicated that while the expression of FKBP5 was affected by the presence of dexamethasone, FASD2 gene showed no alteration in its levels ( Della Bella et al, 2020 ). FASD2 and FKBP5 were previously identified in chondrogenic induction.…”
Section: Gene Expression Profile In Chondrogenesis Of Mscmentioning
confidence: 99%
“…Regarding miRNAs, more than 200 were identified as differentially expressed (102 up and 108 downregulated) in chondrogenic differentiation ( Della Bella et al, 2020 ). Its mRNA targets had relation to PI3K-AKT signaling pathway, NK-kappa B signaling pathway and others.…”
Section: Gene Expression Profile In Chondrogenesis Of Mscmentioning
confidence: 99%
“…Furthermore, the identification of miRNAs allowed to relate them with the circRNA expressed in chondrogenesis, once they can act as miRNAs sponges. For example, some of circRNAs with binding sites for hsa-miR-665 were upregulated (hsa_circRNA_081069, hsa_circRNA_100833, hsa_circRNA_002161), while the miRNA was downregulated ( Della Bella et al, 2020 ). An interesting observation is that while in osteogenesis only 54 piRNAs were differentially expressed, in chondrogenesis it was identified 131 piRNAs, the most part upregulated (73).…”
Section: Gene Expression Profile In Chondrogenesis Of Mscmentioning
confidence: 99%
“…An interesting observation is that while in osteogenesis only 54 piRNAs were differentially expressed, in chondrogenesis it was identified 131 piRNAs, the most part upregulated (73). But future studies need to be performed to understand the role of this class of RNA in differentiation process ( Della Bella et al, 2020 ).…”
Section: Gene Expression Profile In Chondrogenesis Of Mscmentioning
Adipogenesis, osteogenesis and chondrogenesis of human mesenchymal stem/stromal cells (MSC) are complex and highly regulated processes. Over the years, several studies have focused on understanding the mechanisms involved in the MSC commitment to the osteogenic, adipogenic and/or chondrogenic phenotypes. High-throughput methodologies have been used to investigate the gene expression profile during differentiation. Association of data analysis of mRNAs, microRNAs, circular RNAs and long non-coding RNAs, obtained at different time points over these processes, are important to depict the complexity of differentiation. This review will discuss the results that were highlighted in transcriptome analyses of MSC undergoing adipogenic, osteogenic and chondrogenic differentiation. The focus is to shed light on key molecules, main signaling pathways and biological processes related to different time points of adipogenesis, osteogenesis and chondrogenesis.
“…Recently several circRNAs, miRNAs and piRNA were differentially expressed after 7 days of chondrogenic and osteogenic induction ( Della Bella et al, 2020 ). This analysis identified 130 up and 97 downregulated circRNAs in chondrogenesis, of which 15 were also identified in osteogenesis.…”
Section: Gene Expression Profile In Chondrogenesis Of Mscmentioning
confidence: 99%
“…Investigating if the expression of these genes were influenced by dexamethasone, a component of both induction media ( Table 1 ), the cells were exposed only to the compound in monolayer or pellet culture. The results indicated that while the expression of FKBP5 was affected by the presence of dexamethasone, FASD2 gene showed no alteration in its levels ( Della Bella et al, 2020 ). FASD2 and FKBP5 were previously identified in chondrogenic induction.…”
Section: Gene Expression Profile In Chondrogenesis Of Mscmentioning
confidence: 99%
“…Regarding miRNAs, more than 200 were identified as differentially expressed (102 up and 108 downregulated) in chondrogenic differentiation ( Della Bella et al, 2020 ). Its mRNA targets had relation to PI3K-AKT signaling pathway, NK-kappa B signaling pathway and others.…”
Section: Gene Expression Profile In Chondrogenesis Of Mscmentioning
confidence: 99%
“…Furthermore, the identification of miRNAs allowed to relate them with the circRNA expressed in chondrogenesis, once they can act as miRNAs sponges. For example, some of circRNAs with binding sites for hsa-miR-665 were upregulated (hsa_circRNA_081069, hsa_circRNA_100833, hsa_circRNA_002161), while the miRNA was downregulated ( Della Bella et al, 2020 ). An interesting observation is that while in osteogenesis only 54 piRNAs were differentially expressed, in chondrogenesis it was identified 131 piRNAs, the most part upregulated (73).…”
Section: Gene Expression Profile In Chondrogenesis Of Mscmentioning
confidence: 99%
“…An interesting observation is that while in osteogenesis only 54 piRNAs were differentially expressed, in chondrogenesis it was identified 131 piRNAs, the most part upregulated (73). But future studies need to be performed to understand the role of this class of RNA in differentiation process ( Della Bella et al, 2020 ).…”
Section: Gene Expression Profile In Chondrogenesis Of Mscmentioning
Adipogenesis, osteogenesis and chondrogenesis of human mesenchymal stem/stromal cells (MSC) are complex and highly regulated processes. Over the years, several studies have focused on understanding the mechanisms involved in the MSC commitment to the osteogenic, adipogenic and/or chondrogenic phenotypes. High-throughput methodologies have been used to investigate the gene expression profile during differentiation. Association of data analysis of mRNAs, microRNAs, circular RNAs and long non-coding RNAs, obtained at different time points over these processes, are important to depict the complexity of differentiation. This review will discuss the results that were highlighted in transcriptome analyses of MSC undergoing adipogenic, osteogenic and chondrogenic differentiation. The focus is to shed light on key molecules, main signaling pathways and biological processes related to different time points of adipogenesis, osteogenesis and chondrogenesis.
Central Nervous System (CNS) diseases, such as Alzheimer's diseases (AD), Parkinson's Diseases (PD), brain tumors, Huntington's disease (HD), and stroke, still remain difficult to treat by the conventional molecular drugs. In recent years, various gene therapies have come into the spotlight as versatile therapeutics providing the potential to prevent and treat these diseases. Despite the significant progress that has undoubtedly been achieved in terms of the design and modification of genetic modulators with desired potency and minimized unwanted immune responses, the efficient and safe in vivo delivery of gene therapies still poses major translational challenges. Various non‐viral nanomedicines have been recently explored to circumvent this limitation. In this review, an overview of gene therapies for CNS diseases is provided and describes recent advances in the development of nanomedicines, including their unique characteristics, chemical modifications, bioconjugations, and the specific applications that those nanomedicines are harnessed to deliver gene therapies.
Background
Osteoporosis (OP) is a bone disease characterized by reduced amount and quality of bone. This study was designed to explore the role and mechanism of lncRNA IGF2‐AS in the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).
Methods
Human lncRNA and miRNA microarray analyses were performed to measure the differential expression levels of lncRNAs and miRNAs in undifferentiated and osteogenically differentiated BMSCs. lncRNA IGF2‐AS, miR‐3,126‐5p, and KLK4 levels were measured by real‐time quantitative polymerase chain reaction (RT‐qPCR). Osteogenic differentiation of BMSCs was assessed by alkaline phosphatase (ALP) staining and Alizarin Red staining (ARS). Protein levels of osterix (Osx), osteocalcin (OCN), and runt‐related transcription factor 2 (RUNX2) were examined by RT‐PCR and western blot assays. The binding relationship between miR‐3,126‐5p and lncRNA IGF2‐AS or KLK4 was predicted by TargetScan (http://www.targetscan.org/vert_72/) and then verified with a dual‐luciferase reporter assay.
Results
lncRNA IGF2‐AS and KLK4 were highly expressed and miR‐3,126‐5p was weakly expressed in osteogenically differentiated BMSCs. Moreover, lncRNA IGF2‐AS overexpression enhanced the osteogenic differentiation of BMSCs. In contrast, lncRNA IGF2‐AS knockdown showed the opposite trend. Moreover, miR‐3,126‐5p overexpression abolished the lncRNA IGF2‐AS‐mediated osteogenic differentiation of BMSCs. lncRNA IGF2‐AS functions as a sponge of miR‐3,126‐5p to regulate KLK4 expression.
Conclusion
lncRNA IGF2‐AS enhances the osteogenic differentiation of BMSCs by modulating the miR‐3,126‐5p/KLK4 axis, suggesting a promising therapeutic target for bone‐related diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.